Safety and efficacy results from a phase 1 study of DS-8201a in patients with HER2 expressing breast cancers Meeting Abstract
| Authors: | Modi, S.; Tsurutani, J.; Takahashi, S.; Iwata, H.; Park, H.; Redfern, C. H.; Doi, T.; Li, B.; Iwasa, T.; Taira, S.; Hattori, M.; Ma, C. X.; Fisher, J. M.; Naito, Y.; Yonemori, K.; Kawasaki, Y.; Saito, K.; Jikoh, T.; Shahidi, J.; Lee, C. C.; Yver, A.; Tamura, K. |
| Abstract Title: | Safety and efficacy results from a phase 1 study of DS-8201a in patients with HER2 expressing breast cancers |
| Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2017 Dec 5-9 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-02-01 |
| Language: | English |
| ACCESSION: | WOS:000425489402237 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.SABCS17-PD3-07 |
| Notes: | Meeting Abstract: PD3-07 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
